Rosen Law Firm Encourages Corcept Therapeutics Incorporated Investors to Inquire About Securities Class Action Investigation – CORT

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Corcept Therapeutics Incorporated due to allegations of materially misleading business information issued to the investing public [1] Company Summary - Corcept Therapeutics Incorporated is facing scrutiny for potentially misleading information that may have affected its securities [1] - Shareholders who purchased Corcept securities may be entitled to compensation without any out-of-pocket fees or costs through a contingency fee arrangement [1]